3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
24
Non-Muscle Invasive Bladder Neoplasms
5
Hematuria
4
Pain
2
Carcinoma, Transitional Cell
2
Carcinoma in Situ
2
Urinary Bladder Neck Obstruction
1
Urinary Bladder Diseases
1
Urinary Bladder Calculi
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Pain, Postoperative
1
Nephrolithiasis
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Lower Urinary Tract Symptoms
1
Kidney Neoplasms
1
Kidney Diseases
1
Disease
1
Anxiety Disorders
1
Interventions
aldesleukin
43
Sunitinib
42
Cyclophosphamide
30
Nivolumab
29
pembrolizumab
27
Everolimus
27
Interferon-alpha
25
Bevacizumab
23
Sorafenib
22
Interleukin-2
20
fludarabine phosphate
19
Radiotherapy
18
Ipilimumab
18
Filgrastim
18
Axitinib
18
Gene Expression Profiling
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
Radiosurgery
13
fludarabine
11
Doxorubicin
11
Carboplatin
11
Blood Specimen Collection
11
temsirolimus
10
atezolizumab
9
Immunohistochemistry
9
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Cystoscopy
×
Genitourinary
×
Clear all
NCT07037589
2025-11-21
BLUSH
Vastra Gotaland Region
Recruiting
300 enrolled